Clinical Trials Directory

Trials / Terminated

TerminatedNCT04013763

Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin Care

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

Wheat allergy is increasing in Thailand. Some studies show that cutaneous exposure of allergen may cause allergy and there are many wheat containing skin care products that are over-the-counter. So the purpose of our study is to determine level of specific immunoglobulin E antibodies to wheat and omega-5 gliadin in wheat allergy patients after stop using wheat containing skin care products.

Detailed description

All children in this study were sensitized to wheat. Each patient was clinically evaluated, with focus on wheat allergy by medical history, medical examination included skin status (suspected atopic dermatitis or not). Blood sample was taken for baseline determination of immunoglobulin E antibodies to wheat and to omega-5 gliadin. Transepidermal water loss was examined in case with atopic dermatitis. The primary outcome was the specific immunoglobulin E antibodies to wheat and omega-5 gliadin in case that stop using wheat containing skin care product and case that continue using products.

Conditions

Interventions

TypeNameDescription
OTHERwheat containing skin care productsstop or continue using wheat containing skin care products

Timeline

Start date
2019-07-01
Primary completion
2020-08-31
Completion
2020-08-31
First posted
2019-07-10
Last updated
2022-04-08

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT04013763. Inclusion in this directory is not an endorsement.